Clinical trial · Observational
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France: Surgical Thresholds, Geographical Distance, Age and Therapeutic Sequence
NCT05204342CI-TRIAL-00056093Pro-TOCacompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- To study the prognostic effect of the volume of activity
- timeFrame
- at 5 years
- description
- To study the prognostic effect of the volume of activity per center on the risk of recurrence
- measure
- Verify that the therapeutic sequence
- timeFrame
- at 5 years
- description
- Verify that the therapeutic sequence of primary surgery and secondary chemotherapy is a good prognostic factor for overall and specific survival at 5 years
Secondary outcomes (3)
- measure
- Verify that delay in initiation of chemotherapy beyond 4 weeks
- timeFrame
- at 5 years
- description
- Verify that delay in initiation of chemotherapy beyond 4 weeks after surgery is a poor prognostic element on overall and specific survival at 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * \- Diagnosic of Ovarian or Tubal Cancer C56 et C570 * +/- * Carcinose péritonéale C786 * Tumueur maligne secondaire de la plèvre C782, * Tumueur maligne secondaire des ganglions C770 à C779, * Tumueur maligne secondaire du foie C787, * Tumueur maligne secondaire du péritoine C786 Exclusion criteria: * autres causes de : * Carcinose péritonéale C786 * Tumueur maligne secondaire de la plèvre C782, * Tumueur maligne secondaire des ganglions C770 à C779, * Tumueur maligne secondaire du foie C787, * Tumueur maligne secondaire du péritoine C786
References
Publications (0)
Data not yet available
No reference posted for this study.